VPH Analytical Development Leader

WHO ARE WE?

ROPU MIDI is a Regional Operating Unit that covers all local Human Pharma and Animal Health Operating Units across Belgium, Denmark, Norway, Finland, Greece, Portugal, Sweden, and The Netherlands. MIDI has a multicultural and diverse work environment. More than 1.800 employees are striving to work together to improve lives for patients and animals in our region.

THE OPPORTUNITY

Join our Animal Health Research organization in Lelystad and lead a team developing innovative analytical methods that accelerate vaccine and biologics development. You will play a key role in shaping analytical strategies, introducing new technologies, and supporting global vaccine innovation projects. This is a permanent position combining scientific leadership, people management, and cross-functional collaboration in an international research environment.

This position is based in Lelystad (Netherlands) and reports directly to the Scientific Expert ID & Site Head Lelystad.

This is a fantastic opportunity for an experienced professional who wants to be part of a truly innovative and revolutionary team! Join us if you want to make the difference.

HOW YOU’LL FIT IN:

• Lead the Analytical Development team and ensure timely delivery of project objectives.


• Develop and implement analytical methods to characterize vaccine antigens, intermediates, and final products.


• Drive analytical support for research, process development, and technology transfer activities.


• Establish and improve analytical platforms, including immunological, virological, and chromatographic assays.


• Manage laboratory resources, equipment, and scientific staff to ensure efficient operations.


• Collaborate with global stakeholders to deliver robust analytical solutions and high-quality technical data.

YOU BRING:

• PhD or MSc in Virology, Immunology, Biotechnology, Biochemistry, Veterinary Sciences, or related discipline.


• Demonstrated experience in analytical development for vaccines, biologics, or complex biological products.


• Strong knowledge of analytical techniques such as ELISA, virological assays, HPLC/SEC, or related technologies.


• Previous experience in QC - GMP (Good Manufacturing Practices).


• Proven leadership experience in managing scientific teams and laboratory activities.


• Experience working in a regulated development, quality, or research environment.


• Strong communication, stakeholder management, and project leadership skills in an international setting.

WHAT WILL YOU GET IN RETURN?

Next to working in a Global Top Employer certified company that offers you the opportunity to develop and challenge yourself while learning from a fast-paced environment: 

• Be part of a wellbeing-oriented organization (Premium access to Headspace, OpenUP and ongoing support and initiatives related to ways of working to help our employees to stay healthy and constantly improve the physical, emotional, mental, and spiritual well-being) 

• Customized Development plan based on your role and aspirations, with several learning platforms such as LinkedIn Learning Premium (languages + training programs) and our Virtual Campus Lifelong learning at our Virtual Campus | Boehringer Ingelheim (boehringer-ingelheim.com) 

• A competitive salary range based on seniority and skills (plus annual bonus, 8% holiday pay and a company pension scheme) 

• Green mobility package where you get compensated even for cycling to the office – which is an inspiring, sustainable (platinum-certified) building  

• 31 vacation days to re-energize 

Please note that pay information will be shared during the recruitment process.

What’s next? 

Please submit your application before 23rd July 2026. We will have a look at your CV and cover letter. If we see a match, we will invite you for a video call interview to get to know each other. We will keep you posted during the process!

Screening:

In order to comply with applicable export control laws, Boehringer Ingelheim periodically screens business relations (including job applicants) against sanctioned party lists (“SPL”). These checks may be performed by Boehringer Ingelheim or by any of its Affiliates. You acknowledge that Boehringer Ingelheim and/or its Affiliates will screen you against SPL and that for this purpose your personal data may be processed in relevant databases, including databases of third-party vendors that perform SPL screening for or on behalf of Boehringer Ingelheim or its Affiliates which may be located or accessible outside the EU. Boehringer Ingelheim is committed to ensuring an adequate level of protection of your personal data.